Dementia and Storytelling in Vietnam
ConditionAlzheimer Dementia (AD)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorUniversity of Massachusetts, Worcester
About this trial
This project aims to improve knowledge regarding Alzheimer's dementia and related dementias (ADRD) among older adults and their caregivers in Vietnam and promote the early diagnosis of ADRD using a digital storytelling intervention.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Older adults (age ≥ 60 years) residing in one of the four participating communities (communities in rural areas of Phu Tho province with minimum distance of 10 km between participating communities)
Concern about mild cognitive impairment expressed by the participant, caregiver, or healthcare provider, with no formal screening for ADRD
Ability and willingness to provide informed consent
Caregivers of eligible participants will be invited to participate after providing written consent.
Disqualifiers
Current participation in another ADRD study
Severe cognitive impairment as evaluated by study co-investigators
Enrollment in palliative care or diagnosis of a terminal illness
Previous exposure to digital storytelling modules
Trial design
Design model
Parallel
Treatments tested in this trial
Storytelling intervention
BehavioralParticipants will receive a digital storytelling intervention featuring narratives from older adults with mild to moderate Alzheimer's disease and related dementias (ADRD) and their caregivers who have successfully managed the condition. The stories highlight the benefits of early ADRD diagnosis and strategies for managing diagnostic and care-related challenges. The intervention will be delivered at baseline and biweekly thereafter for three months via CIAS, with didactic "Learn More" modules provided following the stories.
Basic information
BehavioralParticipants will receive basic information about Alzheimer's disease and related dementias (ADRD), issued by the Vietnam Ministry of Health (usual care), at baseline and at Month 3.
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: ControlActive comparator 1 intervention
Group B: InterventionExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Intervention Feasibility: Participant Recruitment and Retention
Feasibility will be assessed using recruitment and retention records, including the number of participants approached, reasons for ineligibility or refusal, and study completion rates.
Time frame
Baseline, Month 3, Month 62
Intervention Engagement: Interaction Records from CIAS
Engagement will be assessed using the number of videos watched.
Time frame
Month 3, Month 63
Intervention Engagement: Exit Interview
Information on participants' experiences with the intervention will be collected through exit interviews.
Time frame
Month 64
Intervention Acceptability: System Usability Scale (SUS)
SUS is a 10-item, 5-point Likert scale for subjective assessment of usability. The SUS scores range from 0 to 100. A score of \> 50 indicates that the technology-based interventions are acceptable.
Time frame
Month 3, Month 6Secondary outcomes
1
ADRD Screening/Diagnosis
Rates of ADRD screening and diagnosis will be obtained via interviews and through review of participants' medical records by trained study staff. The diagnosis will be reviewed and confirmed by the study co-investigators (physicians).
Time frame
Month 3, Month 62
Quality of Life: SF-12
The SF-12 is a 12-item scale that assesses health-related quality of life across physical and mental well-being domains. Scores can range from 0 to 100, with higher scores indicating better quality of life.
Time frame
Baseline, Month 3, Month 63
Self-Care: The Self-Care of Chronic Illness Inventory (SC-CII)
SC-CII is a 29-item scale assessing self-care behaviors across three domains: self-care maintenance, self-care monitoring, and self-care management. Scores range from 0 to 100, with higher scores indicating better self-care.
Time frame
Baseline, Month 3, Month 6Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Massachusetts, Worcester
Lead sponsor
Alzheimer's Association
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: